Trials / Recruiting
RecruitingNCT07191444
A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease
Efficacy and Safety of Firsekibart Versus Anakinra in Adult-Onset Still's Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy and safety of firsekibart versus anakinra in patients with AOSD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Firsekibart | Firsekibart will be administered according to the protocol |
| BIOLOGICAL | Anakinra | Anakinra will be administered according to the protocol |
Timeline
- Start date
- 2025-09-24
- Primary completion
- 2026-12-01
- Completion
- 2027-07-31
- First posted
- 2025-09-24
- Last updated
- 2026-04-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07191444. Inclusion in this directory is not an endorsement.